Related references
Note: Only part of the references are listed.Prostate cancer genomics, biology, and risk assessment through genome-wide association studies
Hidewaki Nakagawa et al.
CANCER SCIENCE (2012)
RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies
Lin-Bo Gao et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism
Qiang Nie et al.
EUROPEAN JOURNAL OF CANCER (2011)
Evaluation of the influence of polymorphic variants CYP1A1*2B, CYP1B1*2, CYP3A4*1B, GSTM1*0, and GSTT1*0 in prostate cancer
Iara S. Rodrigues et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer
Vivek Kumar et al.
CHEMOSPHERE (2010)
Single and Multigenic Analysis of the Association between Variants in 12 Steroid Hormone Metabolism Genes and Risk of Prostate Cancer
Joke Beuten et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Xenobiotic Metabolizing Gene Variants, Dietary Heterocyclic Amine Intake, and Risk of Prostate Cancer
Stella Koutros et al.
CANCER RESEARCH (2009)
Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients
Parag P. Shah et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
Distributions of Hardy-Weinberg Equilibrium Test Statistics
R. V. Rohlfs et al.
GENETICS (2008)
Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: Gene-environment interaction and risk of prostate cancer
Rama D. Mittal et al.
DNA AND CELL BIOLOGY (2007)
Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer
Julie M. Cunningham et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk:: a meta-analysis
Chengwen Chen et al.
JOURNAL OF HUMAN GENETICS (2007)
Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data
Jan O. Friedrich et al.
BMC MEDICAL RESEARCH METHODOLOGY (2007)
Variant in sex hormone-binding globulin gene and the risk of prostate cancer
Sonja I. Berndt et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility:: A case-control study in a Han nationality population in Southern China
Jie Yang et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia and invasive cervical cancer
Cagatay Taskiran et al.
GYNECOLOGIC ONCOLOGY (2006)
Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk:: an exploratory genotype-environment interaction study
LA Quiñones et al.
ASIAN JOURNAL OF ANDROLOGY (2006)
Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk
NL Nock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
A method for meta-analysis of molecular association studies
A Thakkinstian et al.
STATISTICS IN MEDICINE (2005)
Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: Exploring some gene-gene and gene-environment interactions
DD Caceres et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2005)
The complex genetic epidemiology of prostate cancer
DJ Schaid
HUMAN MOLECULAR GENETICS (2004)
Constitutive and inducible expression of cytochromes P4501A (CYP1A1 and CYP1A2) in normal prostate and prostate cancer cells
KM Sterling et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population
D Aktas et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Cytochrome P450 gene polymorphism and cancer
JAG Agúndez
CURRENT DRUG METABOLISM (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk
BL Chang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people
C Acevedo et al.
PROSTATE (2003)
Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study
K Suzuki et al.
CANCER LETTERS (2003)
The epidemiology of prostate cancer
P Boyle et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
A review of genetic polymorphisms and prostate cancer risk
SS Coughlin et al.
ANNALS OF EPIDEMIOLOGY (2002)
Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population
M Murata et al.
CANCER LETTERS (2001)
Share Paper
